secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELEFLEX INC (TFX)
CIK:        0000096943
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0000096943-25-000112
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teleflex Q2 adj. EPS $3.73 beats $3.42 YoY; raises FY outlook on BIOTRONIK deal
-------------------------------------------------------------------------------

- GAAP revenue $780.9M (+4.2% YoY); adjusted constant currency revenue growth +1.0%.
- GAAP diluted EPS $2.77 vs $1.69; adjusted diluted EPS $3.73 vs $3.42.
- Full-year GAAP revenue growth guidance raised to 9.0%-10.0% (from 1.3%-2.3%) due to BIOTRONIK acquisition.
- FY adjusted diluted EPS guidance raised to $13.90-$14.30 from $13.20-$13.60.
- Interventional segment revenue surged 20.4% as reported; OEM and Interventional Urology each declined over 8%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/96943/000009694325000112/0000096943-25-000112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/96943/000009694325000112/tfx-20250731.htm
  HTML page:      https://secwatch.observer/filing/0000096943-25-000112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer